Clinical Trials Logo

Hip Arthritis clinical trials

View clinical trials related to Hip Arthritis.

Filter by:

NCT ID: NCT05824845 Recruiting - Knee Arthritis Clinical Trials

QIST Collaborative - Arthroplasty Research Cohort (ARC) Study

Start date: July 13, 2023
Phase:
Study type: Observational

The ARC Study is a national observational cohort study to investigate patient reported and clinical outcomes after hip and knee replacements. The study has the following objectives: 1. To evaluate outcomes following hip and knee replacements. 2. To determine risk factors for adverse outcomes in primary hip and knee replacements. 3. To identify targets for future research and intervention in patients undergoing primary hip and knee replacements 4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in the ARC Study as comparison or control data for trial participants who have been randomised to receive one or more interventions. Participants are recruited and consented online. Patients are invited to participate by collaborating surgical teams nationally in outpatient clinics at the time of being added to a waiting list, in addition to an advertising campaign to recruit patients. They are directed to an online portal where they will be able to review further information. Consent and data collection is completed electronically through patients entering data online. Baseline demographics and characteristics are recorded, including details of socio-demographics, lifestyle, health status and patient reported outcome measures (PROMs). Patients then undergo hip/knee replacement and postoperative rehabilitation according to the standard care and protocols of the hospital and the preferences of their treating surgeon. Follow-up data, including PROMs, is collected via online questionnaires up to two years following surgery. The study will ultimately also enable multiple trials to be embedded within the cohort study, using a 'Trials within Cohorts' (TwiCs) methodology.

NCT ID: NCT05543941 Recruiting - Knee Osteoarthritis Clinical Trials

Evaluating XPERIENCE™ Advanced Surgical Irrigation

XPERIENCE
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

A prospective, multi-center, double-arm, parallel, interventional, randomized, controlled clinical trial to assess the rate of periprosthetic joint infection (PJI) in patients undergoing primary total knee arthroplasty (TKA), total hip arthroplasty (THA) or hip resurfacing (HR) with XPERIENCE™ (XP) Advanced Surgical Irrigation versus dilute Betadine (DB).

NCT ID: NCT05443243 Completed - Hip Arthritis Clinical Trials

Is a THA Stem in Varus a Risk Factor of Long-term Mechanical Complication

PTHVarus
Start date: May 13, 2022
Phase:
Study type: Observational

The objective of this study is to compare the long-term survival as well as the functional and radiographic results of the rods in the alignment of the varus to the stems in the neutral alignment by comparing 2 groups of implanted Total Hip Arthroplasty. 1 group of stems implanted in varus position. 1 group of stems implanted in neutral position

NCT ID: NCT05227924 Recruiting - Clinical trials for Femoral Neck Fractures

Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty

Start date: September 15, 2021
Phase:
Study type: Observational

The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.

NCT ID: NCT05199870 Recruiting - Hip Fractures Clinical Trials

MDR - PMCF Study for Echo FX Stem With RingLoc Bipolar Acetabular Cup and Femoral Head

Start date: December 17, 2021
Phase:
Study type: Observational

The objective of this retrospective enrollment and prospective follow-up study is to confirm safety, performance, and clinical benefits of the Echo FX Stem with the RingLoc Bipolar Acetabular Cup and Femoral Head in hip hemiarthroplasty (implants and instrumentation) at a minimum of 10 years follow-up. All available retrospective data will be collected from each patient and a prospective aspect to the study will be necessary to reach the 10-year time point.

NCT ID: NCT05142462 Active, not recruiting - Hip Fractures Clinical Trials

Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup

Start date: October 27, 2021
Phase:
Study type: Observational

EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety

NCT ID: NCT05093361 Completed - Hip Arthritis Clinical Trials

Randomized Controlled Trial of Total Hip Arthroplasty

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effect of total hip arthroplasty and conservative treatment to hip pain, to activities of daily life and to the quality of life in patients with hip osteoarthritis.

NCT ID: NCT04995822 Active, not recruiting - Hip Fractures Clinical Trials

Post Market Clinical Follow-up of EUROSTEM Femoral Stem

Start date: May 21, 2021
Phase:
Study type: Observational

EUROSSTEM is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSTEM performances and safety

NCT ID: NCT04993638 Recruiting - Hip Fractures Clinical Trials

Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE

Start date: June 1, 2021
Phase:
Study type: Observational

EUROSCUP MOBILE is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP MOBILE performances and safety

NCT ID: NCT04788719 Completed - Clinical trials for Total Hip Arthroplasty

Pre and Postoperative Gait Analysis of Randomized Patient to 2 Different Cement Fixation Methods

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The primary goal of Total Hip Replacement (THR) surgery in the treatment of hip osteoarthritis is to reduce pain and restore hip function in order to increase patient mobility and quality of life. Two different cement fixation methods are used in order to insert THR implants. This will be done before and after surgery in 2 groups randomized to either of 2 cement fixation methods. Gait analysis preoperative and 2 year after surgery.